Dermatologic surgery

Crown Aesthetics, proud provider of ProGen PRP™ Advantage and SkinPen® Precision, announces partnership with Cosmetic Skin & Surgery Center

Retrieved on: 
Tuesday, June 29, 2021

This partnership will support the development of a suite of medical education events focusing on the significant benefits offered by both ProGen PRP Advantage and SkinPen Precision1.

Key Points: 
  • This partnership will support the development of a suite of medical education events focusing on the significant benefits offered by both ProGen PRP Advantage and SkinPen Precision1.
  • A Fellow of the American Society for Dermatologic Surgery, Dr. Rapaport has consistently been a leader in Aesthetic Surgery.
  • To have one of the top PRP specialists in the country excited to work with ProGen PRP is extremely validating."
  • Made in the USA, ProGen Advantage isan easy to use, single spin system that features 15ml and 30ml tubes, yielding 7-15ml of PRP.

Sciton U.K. Announces Central London Flagship Showroom and Training Centre in Partnership with Skin Group International Ltd (SGI)

Retrieved on: 
Friday, May 14, 2021

"Harley Street in London represents an area well known for excellence in medical aesthetics.

Key Points: 
  • "Harley Street in London represents an area well known for excellence in medical aesthetics.
  • Sciton offers aesthetic and medical devices for women\'s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction.
  • Sciton operates on a worldwide basis with direct sales teams in the United States, Canada, Australia, United Kingdom, Ireland, Japan and distributor partners in more than 45 countries.
  • For more information, and a complete listing of Sciton systems, visit www.sciton.com .\n'

Olansky Dermatology & Aesthetics and partners donate shade structure to Atlanta's Mary Lin Elementary School

Retrieved on: 
Tuesday, May 11, 2021

b'ATLANTA, May 11, 2021 /PRNewswire-PRWeb/ -- Olansky Dermatology & Aesthetics, in partnership with the American Academy of Dermatology (AAD) and the Georgia Society of Dermatology and Dermatologic Surgery, recently donated a sunshade structure to Mary Lin Elementary School in Candler Park.

Key Points: 
  • b'ATLANTA, May 11, 2021 /PRNewswire-PRWeb/ -- Olansky Dermatology & Aesthetics, in partnership with the American Academy of Dermatology (AAD) and the Georgia Society of Dermatology and Dermatologic Surgery, recently donated a sunshade structure to Mary Lin Elementary School in Candler Park.
  • Designed to help students avoid skin damage and possible dermatological illnesses, the structure serves as an example of Olansky Dermatology & Aesthetics\' commitment to community-minded efforts.\n"In front of the school, we have a wide walkway," says Alice Brookner, co-president of Mary Lin Elementary School\'s PTA.
  • "We\'re incredibly grateful to Olansky Dermatology & Aesthetics, the American Academy of Dermatology (AAD), and the Georgia Society of Dermatology and Dermatologic Surgery for helping make it a reality for our students, faculty, and parents.
  • "\nTo make an appointment with Olansky Dermatology & Aesthetics, call 404-355-5484 or visit OlanskyDermatology.com .\nOlansky Dermatology & Aesthetics is your dermatology solution.

Global Aesthetic Medical Laser Systems Market Report 2021: Skin Rejuvenation Segment to Contribute Larger Share to Market During 2020-2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, April 26, 2021

b'The "Aesthetic Medical Laser Systems Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type; Application; End User and Geography" report has been added to ResearchAndMarkets.com\'s offering.\nAesthetic Medical Laser Systems Market was valued at US$ 956.87 million in 2019 and it is projected to reach US$ 1,961.00 million by 2027; it is expected to grow at a CAGR of 9.6% during 2020-2027.\nIncrease in aesthetic/cosmetic procedures and broad medical applications of laser systems are among the key factors fueling the growth of the aesthetic medical laser systems market.

Key Points: 
  • b'The "Aesthetic Medical Laser Systems Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type; Application; End User and Geography" report has been added to ResearchAndMarkets.com\'s offering.\nAesthetic Medical Laser Systems Market was valued at US$ 956.87 million in 2019 and it is projected to reach US$ 1,961.00 million by 2027; it is expected to grow at a CAGR of 9.6% during 2020-2027.\nIncrease in aesthetic/cosmetic procedures and broad medical applications of laser systems are among the key factors fueling the growth of the aesthetic medical laser systems market.
  • Further, medical tourism offers lucrative opportunities to the global aesthetic medical laser systems market players.
  • However, the high cost of aesthetic medical laser systems might hinder the market growth.\nBased on application, the aesthetic medical laser systems market is segmented into hair removal, acne and scars, skin rejuvenation, pigmented lesions, leg and varicose veins, and others.
  • S.p.A; and STRATA Skin Sciences are among the key players operating in the aesthetic medical laser systems market.\nThese companies focus on partnerships, product launches, and collaborations to sustain their market positions.

ASDSA Alerts Nation's Governors to New Trend in Anti-transgender Legislation

Retrieved on: 
Wednesday, April 14, 2021

b'ROLLING MEADOWS, Ill., April 14, 2021 /PRNewswire-PRWeb/ --The American Society for Dermatologic Surgery Association (ASDSA) has sent a letter to all 50 state governors along with legislative leaders, alerting them to the increase in anti-transgender legislation that is proliferating in state legislatures across the country.

Key Points: 
  • b'ROLLING MEADOWS, Ill., April 14, 2021 /PRNewswire-PRWeb/ --The American Society for Dermatologic Surgery Association (ASDSA) has sent a letter to all 50 state governors along with legislative leaders, alerting them to the increase in anti-transgender legislation that is proliferating in state legislatures across the country.
  • Governors must do everything they can to protect their transgender citizens, which includes vetoing any of these dangerous and medically unfounded bills that come across their desk.
  • Visit http://asds.net/diversity to learn more about ASDS / ASDSA\'s diversity initiatives.\nWith a membership of 6,400+ physicians, ASDSA is a 501(c) (6) association, dedicated to education and advocacy on behalf of dermatologic surgeons and their patients.
  • For more information, visit http://asds.net/ASDSA .\n'

Facial Skin Ablative Treatment Market Revenue Worth $8,394.3 Million by 2030 says P&S Intelligence

Retrieved on: 
Tuesday, April 6, 2021

Due to this factor, the global facial skin ablative treatment market revenue , which was $4,134.6 million in 2019, will reach $8,394.3 million by 2030, at a 7.8% CAGR between 2020 and 2030, according to P&S Intelligence.

Key Points: 
  • Due to this factor, the global facial skin ablative treatment market revenue , which was $4,134.6 million in 2019, will reach $8,394.3 million by 2030, at a 7.8% CAGR between 2020 and 2030, according to P&S Intelligence.
  • This is why RF microneedling is widely used for scar treatment, skin tightening, and many other facial skin procedures.
  • Browse detailed report with COVID-19 impact analysis on Facial Skin Ablative Treatment Market Research Report: By Technology (Radiofrequency Microneedling, Dermal Fillers, Laser Skin Resurfacing, Mesotherapy), Application (Wrinkles, Aging, Acne and Other Scars, Hyperpigmentation), Demography (Generation X, Baby Boomers, Generation Y, Generation Z) - Global Industry Analysis and Demand Forecast to 2030 @ https://www.psmarketresearch.com/market-analysis/facial-skin-ablative-tr...
    Presently, North America generates the highest revenue for facial skin ablative treatment market players.
  • Key companies in the global facial skin ablative treatment market include Lumenis Ltd., Alma Lasers Ltd., Cutera Inc., Syneron Medical Ltd., EL.EN.

Facial Skin Ablative Treatment Market Revenue Worth $8,394.3 Million by 2030 says P&S Intelligence

Retrieved on: 
Tuesday, April 6, 2021

Due to this factor, the global facial skin ablative treatment market revenue , which was $4,134.6 million in 2019, will reach $8,394.3 million by 2030, at a 7.8% CAGR between 2020 and 2030, according to P&S Intelligence.

Key Points: 
  • Due to this factor, the global facial skin ablative treatment market revenue , which was $4,134.6 million in 2019, will reach $8,394.3 million by 2030, at a 7.8% CAGR between 2020 and 2030, according to P&S Intelligence.
  • This is why RF microneedling is widely used for scar treatment, skin tightening, and many other facial skin procedures.
  • Browse detailed report with COVID-19 impact analysis on Facial Skin Ablative Treatment Market Research Report: By Technology (Radiofrequency Microneedling, Dermal Fillers, Laser Skin Resurfacing, Mesotherapy), Application (Wrinkles, Aging, Acne and Other Scars, Hyperpigmentation), Demography (Generation X, Baby Boomers, Generation Y, Generation Z) - Global Industry Analysis and Demand Forecast to 2030 @ https://www.psmarketresearch.com/market-analysis/facial-skin-ablative-tr...
    Presently, North America generates the highest revenue for facial skin ablative treatment market players.
  • Key companies in the global facial skin ablative treatment market include Lumenis Ltd., Alma Lasers Ltd., Cutera Inc., Syneron Medical Ltd., EL.EN.

Worldwide Facial Skin Ablative Treatment Industry - by Technology, Application and Demography - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 30, 2021

The "Facial Skin Ablative Treatment Market Research Report: By Technology, Application, Demography - Global Industry Analysis and Demand Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Facial Skin Ablative Treatment Market Research Report: By Technology, Application, Demography - Global Industry Analysis and Demand Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The market was valued at $4,134.6 million in 2019, and it is expected to reach $8,394.3 million by 2030.
  • The technology segment of the facial skin ablative treatment market is classified into dermal fillers, laser skin resurfacing, radiofrequency (RF) microneedling, and mesotherapy.
  • Furthermore, the Asia-Pacific (APAC) facial skin ablative treatment market is expected to display the highest growth rate during the forecast period.

Denise M. Guevara, BS, RDE, D.O, FAAD is recognized by Continental Who's Who

Retrieved on: 
Thursday, March 25, 2021

A Board Certified Dermatologist, Dr. Guevara is currently leading a remarkable career demonstrating the highest level of professionalism and integrity.

Key Points: 
  • A Board Certified Dermatologist, Dr. Guevara is currently leading a remarkable career demonstrating the highest level of professionalism and integrity.
  • She offers a vast repertoire of professional experience and expertise in dermatologic surgery, skin cancer prevention and treatment, and aesthetic medicine.
  • In her current capacity, she has served patients for the past 10 years at Skin and Cancer Associates and The Center for Cosmetic Enhancement.
  • She performs a blend of cosmetic and dermatologic services with offices in Margate, Tamarac, and Wellington.

Leading American Dermatologist Dr. Mitchell Kline to Join Innocan Pharma's Scientific Advisory Committee

Retrieved on: 
Tuesday, March 23, 2021

Dr Kline has served on the boards of certain leading organizations including Healthright International, Whitehead Institute-MIT, American Academy of Dermatology, Dermatology Foundation, New York Academy of Sciences and the American Society for Dermatologic Surgery.

Key Points: 
  • Dr Kline has served on the boards of certain leading organizations including Healthright International, Whitehead Institute-MIT, American Academy of Dermatology, Dermatology Foundation, New York Academy of Sciences and the American Society for Dermatologic Surgery.
  • Dr. Kline said, "Working with Innocan will provide a platform and an opportunity to bring innovative delivery and anti-inflammatory technologies to the wellness and cosmetics industries.
  • Iris Bincovich, Innocan's CEO, said, "We are deeply humbled to have been able to add Dr. Kline to our Scientific Advisory Committee.
  • The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.